Osteosarcoma
246
60
80
83
Key Insights
Highlights
Success Rate
75% trial completion
Published Results
33 trials with published results (13%)
Research Maturity
83 completed trials (34% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.4%
28 terminated out of 246 trials
74.8%
-11.8% vs benchmark
4%
9 trials in Phase 3/4
40%
33 of 83 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 83 completed trials
Clinical Trials (246)
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
AOH1996 for the Treatment of Refractory Solid Tumors
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Methionine PET/CT Studies In Patients With Cancer
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
Losartan + Sunitinib in Treatment of Osteosarcoma
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Musculoskeletal Cancers Remote Monitoring and Care
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma